[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Krystal Biotech Inc (KRYS)

Krystal Biotech Inc (KRYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Krystal Biotech Inc 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 USA

www.krystalbio.com Employees: 295 P: 412-586-5830

Sector:

Medical

Description:

Krystal Biotech, Inc. is a gene therapy company. It engaged in developing and commercializing novel treatments for patients suffering from dermatological diseases. Krystal Biotech, Inc. is based in Pittsburgh, United States.

Key Statistics

Overview:

Market Capitalization, $K 10,714,208
Enterprise Value, $K 10,217,908
Shares Outstanding, K 29,480
Float, K 25,618
% Float 86.90%
Short Interest, K 3,518
Short Float 11.93%
Days to Cover 7.19
Short Volume Ratio 0.81
% of Insider Shareholders 13.10%
% of Institutional Shareholders 86.29%

Financials:

Annual Sales, $ 389,130 K
Annual Net Income, $ 204,830 K
Last Quarter Sales, $ 116,360 K
Last Quarter Net Income, $ 55,930 K
EBIT, $ 178,810 K
EBITDA, $ 185,360 K

Growth:

1-Year Return 130.86%
3-Year Return 202.09%
5-Year Return 499.74%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 500.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 1.83 on 05/04/26
Next Earnings Date 08/03/26 [--]
Earnings Per Share ttm 7.48
EPS Growth vs. Prev Qtr 7.65%
EPS Growth vs. Prev Year 52.50%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

KRYS Ratios

Ratio
Price/Earnings ttm 48.91
Price/Earnings forward 48.47
Price/Earnings to Growth N/A
Return-on-Equity % 19.25%
Return-on-Assets % 17.62%
Profit Margin % 52.64%
Debt/Equity 0.00
Price/Sales 27.71
Price/Cash Flow 50.93
Price/Book 8.57
Book Value/Share 43.31
Interest Coverage 2.29
60-Month Beta 0.50
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.